- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- March 2026
- 280 Pages
Global
From €5228EUR$5,850USD£4,520GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4013EUR$4,490USD£3,469GBP
- Report
- June 2025
- 400 Pages
Global
From €4423EUR$4,949USD£3,824GBP
- Report
- June 2025
Global
From €6703EUR$7,500USD£5,795GBP
- Report
- May 2023
- 169 Pages
Global
From €2100EUR$2,350USD£1,816GBP
- Report
- September 2024
- 150 Pages
Global
From €5318EUR$5,950USD£4,597GBP
- Report
- January 2025
- 250 Pages
Global
From €4468EUR$4,999USD£3,863GBP
- Report
- January 2025
- 250 Pages
Global
From €4468EUR$4,999USD£3,863GBP
- Report
- March 2024
- 91 Pages
North America
From €1341EUR$1,500USD£1,159GBP
- Report
- June 2024
- 211 Pages
Global
From €4464EUR$4,995USD£3,860GBP
- Report
- July 2024
- 154 Pages
Global
From €3798EUR$4,250USD£3,284GBP
- Report
- August 2023
- 117 Pages
Global
From €3500EUR$4,195USD£3,132GBP
- Report
- November 2025
- 132 Pages
Global
From €849EUR$950USD£734GBP
€1717EUR$2,058USD£1,536GBP

The Immunodeficiency market is a subset of the Allergy and Immunology field, which focuses on the diagnosis and treatment of immune system disorders. Immunodeficiency is a condition in which the body's immune system is weakened or unable to function properly, making it more susceptible to infections and other diseases. Common immunodeficiency disorders include primary immunodeficiency diseases, secondary immunodeficiency diseases, and acquired immunodeficiency syndrome (AIDS). Treatment for immunodeficiency disorders typically involves medications, such as immunoglobulins, to boost the body's immune system, as well as lifestyle changes to reduce the risk of infection.
Companies in the Immunodeficiency market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. These companies specialize in the development and manufacture of immunoglobulins, as well as other treatments for immunodeficiency disorders. Show Less Read more